Leila Rezaie Shirmard

ANTI-TUBERCULOSIS DRUGS RELATED HEPATOTOXICITY; INCIDENCE, RISK FACTORS, PATTERN OF CHANGES IN LIVER ENZYMES AND OUTCOME

Hossein Khalili, Simin Dashti‐Khavidaki, Mehrnaz Rasoolinejad et al. · SHILAP Revista de lepidopterología · 2009 · 45 citations · Full text

Nanoparticulate fingolimod delivery system based on biodegradable poly (3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV): design, optimization, characterization and in-vitro evaluation

Leila Rezaie Shirmard, Nika Bahari Javan, Mohammad Reza Khoshayand et al. · Pharmaceutical Development and Technology · 2015 · 37 citations

Nanomedicine, Phbv-based Fingolimod Nanoparticles, Engineering +14

Application of Artificial Neural Networks in the Design and Optimization of a Nanoparticulate Fingolimod Delivery System Based on Biodegradable Poly(3-Hydroxybutyrate-Co-3-Hydroxyvalerate)

Shadab Shahsavari, Leila Rezaie Shirmard, Mohsen Amini et al. · Journal of Pharmaceutical Sciences · 2016 · 31 citations

Tissue Engineering, Biofunctional Material, Engineering +7

Preparation, characterization and in vivo evaluation of a combination delivery system based on hyaluronic acid/jeffamine hydrogel loaded with PHBV/PLGA blend nanoparticles for prolonged delivery of Teriparatide

Nika Bahari Javan, Hamed Montazeri, Leila Rezaie Shirmard et al. · European Journal of Pharmaceutical Sciences · 2017 · 27 citations

Tissue Engineering, Nanomedicine, Combination Delivery System +11

Preparation, statistical optimisation and<i>in vitro</i>characterisation of poly (3-hydroxybutyrate-co-3-hydroxyvalerate)/poly (lactic-co-glycolic acid) blend nanoparticles for prolonged delivery of teriparatide

Nika Bahari Javan, Leila Rezaie Shirmard, Nersi Jafary Omid et al. · Journal of Microencapsulation · 2016 · 26 citations